Clinical Trials in Tennessee

Showing 4521-4540 of 15,329 trials

Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students

NCT06567496

Exploring the impact of a virtual reality program, First Resort on graduate physical therapy student wellness and academic success.

Mental StressAnxietyDepression+1 more

Belmont University23 participantsStarted Aug 2024

Nashville, Tennessee, United States

COMPLETEDPhase 229 miles

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240

Open-label, single-arm study designed to evaluate the body weight response to setmelanotide administered subcutaneously (SC) daily in participants with hypothalamic obesity (HO).

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.18 participantsStarted Jun 2021

San Diego, California, United States • Gainesville, Florida, United States • Saint Paul, Minnesota, United States +2 more locations

RECRUITINGPhase 229 miles

Different Doses of Naronapride Vs. Placebo in Gastroparesis

NCT05621811

This is a double-blind, randomized, multicenter, placebo-controlled, comparative phase II dose-finding trial. The trial will be conducted with four treatment groups in the form of a parallel group comparison and will serve to compare oral treatment with daily doses of 10, 20, or 40 mg Naronapride vs. placebo for the treatment of patients with Gastroparesis.

Gastroparesis

Dr. Falk Pharma GmbH320 participantsStarted Jan 2023

Chula Vista, California, United States • Lomita, California, United States • Clearwater, Florida, United States +19 more locations

Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Find Trials by Condition in Tennessee

Framing Eighteen Coils in Cerebral Aneurysms Trial

Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Rituximab + Immunotherapy in Follicular Lymphoma

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors